TrialArthritis & rheumatology (Hoboken, N.J.)2017

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.

Richard Furie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.